基于CRISPR/Cas9系统对干酪乳杆菌进行红色荧光蛋白标记

本实验利用CRISPR/Cas9系统对干酪乳杆菌(Lactobacillus casei) LC2W进行红色荧光蛋白(red fluorescent protein,RFP)标记,用于研究干酪乳杆菌在肠道内的分布和定植状况,评价其作为益生菌的功能。首先,基于本实验室已有的干酪乳杆菌CRISPR/Cas9编辑质粒pLCNICK-1628构建重组质粒pLCNICK-1628-RFP,电转入干酪乳杆菌LC2W感受态细胞中,使干酪乳杆菌基因组中的LC2W-1628基因被红色荧光蛋白基因替换,从而使干酪乳杆菌LC2W能表达出红色荧光蛋白。得到红色荧光标记的干酪乳杆菌LC2W突变株后,测定了其荧光强度-OD600标准曲线,发现RFP在干酪乳杆菌LC2W中能稳定表达。     

应用PMA-qPCR方法快速准确检测发酵乳制品中副干酪乳杆菌活菌的研究

目的 建立快速、准确检测发酵乳制品中副干酪乳杆菌活菌的方法.方法 发酵乳制品中副干酪乳杆菌先经PMA处理后,采用沸水浴的方法提取副干酪乳杆菌基因组,然后通过qPCR方法检测发酵乳制品中的活菌.结果 副干酪乳杆菌经90℃处理6 min,即为膜损伤菌:PMA能够抑制107 CFU/mL死菌DNA的扩增,而不影响活菌DNA的扩增;PMA-qPCR能够准确检测到样品中活菌.结论 建立了一种快速、准确的方法检测发酵乳制品中的副干酪乳杆菌活菌.     

降血压乳酸菌发酵乳对原发性高血压大鼠的降压效果

目的对具有血管紧张素转化酶(ACE)抑制活性的乳酸菌DM9057发酵乳的抗胃肠道酶解能力及原发性高血压大鼠(SHR)体内降压效果进行研究。方法以10 ml/kg和2.5 ml/kg发酵乳一次性和连续灌胃原发性高血压大鼠。结果 DM9057发酵乳具有较好的抗胃肠道酶能力,并且2个剂量均具有较好的降血压效果,其中以10 ml/kg剂量效果最为显著,一次性和连续灌胃后,最大降压值为(17.97±3.82)、(25.46±5.06)mmHg。结论乳酸菌DM9057发酵乳具有较强的抗胃肠道能力,同时在原发性高血压大鼠体内能够发挥一定的降血压作用。     

喂饲Lactobacillus casei Zhang对大鼠体内脂质代谢的影响

从内蒙古锡林郭勒盟正蓝旗传统酸马奶中分离筛选到1株降胆固醇功效较好的乳杆菌Lactobacillus．casei Zhang。用Lb．casei Zhang灌胃高脂血症模型大鼠研究其对血清总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)的影响。结果表明:灌胃14 d后,Lb．casei Zhang热致死菌体组大鼠血清中TC浓度较对照组显著降低(P<0．01),TG浓度虽有降低但不呈显著性,同时HDL-C浓度显著升高(P<0．05);Lb．casei Zhang活菌体组大鼠血清中TC、TG浓度均有所降低,HDL-C浓度升高,但未呈显著性。灌胃28 d后,Lb．casei Zhang热致死菌体组大鼠血清中TC浓度较对照组显著降低(P<0．05),Lb．casei Zhang活菌体组TC浓度及两组TG、LDL-C浓度降低,但差异不显著,HDL-C未发生明显的改变。Lb．casei Zhang热致死菌体组和活菌体组粪便中的胆酸含量均增高,但只有热致死菌体组差异显著(P<0．05)。通过实验表明Lb．casei Zhang通过菌体对胆固醇的吸收吸附及减少肝肠循环中的胆酸来达到降血脂的功效。     

乳杆菌胞外多糖对人体粪便菌群及其产生短链脂肪酸的影响

目的在体外利用7名志愿者的新鲜粪便作为来源,选择菊粉作为对照,研究干酪乳杆菌LC2W与鼠李糖乳杆菌Y37胞外多糖对人体肠道菌群的影响。方法利用PCR-DGGE(变性梯度凝胶电泳)方法分析样品中菌群组成,采用高效液相色谱的方法分析短链脂肪酸组成。结果与菊粉相比,粪便菌群在添加乳杆菌胞外多糖培养后,可以促进短链脂肪酸的生成,保持肠道菌群的多样性。结论干酪乳杆菌LC2W与鼠李糖乳杆菌Y37的胞外多糖在体外有调节粪便菌群的作用。     

叠氮溴化丙锭-荧光定量PCR法实时快速检测5种乳杆菌活菌数方法的建立与应用

【背景】乳杆菌属是发酵食品中最常见的微生物之一,与食品的品质和安全密切相关,定量检测乳杆菌活菌数、解析乳杆菌群落组成对发酵乃至肠道微生物等具有重要意义。【目的】建立一种在种水平上定量检测5种乳杆菌活菌数的叠氮溴化丙锭-荧光定量PCR (propidium monoazide-quantitative PCR,PMA-qPCR)检测方法并探讨其适用性。【方法】以植物乳杆菌、发酵乳杆菌、短乳杆菌、嗜酸乳杆菌和干酪乳杆菌等发酵食品中常见的5种乳杆菌为目标菌株,查找并筛选特异性引物用于荧光定量PCR (qPCR)检测,优化叠氮溴化丙锭(PMA)处理条件,测定PMA-qPCR检测法的特异性、灵敏度及可靠性。最后利用PMA-qPCR法检测黄酒酿造过程中5种乳杆菌的活菌数。【结果】PMA最佳处理条件为：浓度20 μmol/L下暗处理15 min后曝光15 min,此时可抑制样品中99.89%的死菌DNA扩增。该方法特异性高,能够准确识别5种乳杆菌;线性关系强,R2>0.98;灵敏度高,检测限为101.8?103.2 CFU/mL;重复性好,Cq值变异系数小于1%;与平板计数相比差异不显著(统计学上),p>0.05。利用该方法检测黄酒中5种乳杆菌的活菌数,发现发酵乳杆菌、干酪乳杆菌和短乳杆菌是主要的乳杆菌(总计占比59%?89%),与已知黄酒酿造中乳杆菌群落组成相符。【结论】建立的PMA-qPCR法能够快速、准确地检测5种乳杆菌的活菌数,为解析样品中乳杆菌的实时组成及检测具有活性但不可培养(viable but nonculturable,VBNC)状态的乳杆菌提供了可靠的手段。     

益生菌拮抗阪崎肠杆菌的初步研究

目的研究鼠李糖乳杆菌和植物乳杆菌等8种常见益生菌对阪崎肠杆菌的拮抗作用。方法采用牛津杯法测定益生菌耗尽上清对阪崎肠杆菌的抑菌圈,获得对阪崎肠杆菌具有较强抑菌能力的鼠李糖乳杆菌和植物乳杆菌;采用混合培养法对2株益生菌与阪崎肠杆菌的拮抗竞争能力进行测试。结果 8种益生菌耗尽上清均能抑制阪崎肠杆菌,其抑菌能力具有热稳定性且依赖于酸性pH环境。阪崎肠杆菌(107CFU/mL)与鼠李糖乳杆菌(108CFU/mL或109CFU/mL)共孵育至24 h,其活菌量开始逐渐下降,至120 h孵育结束下降到105CFU/mL;菌量比为1:10的阪崎肠杆菌与植物乳杆菌共孵育至24 h,其活菌量开始逐渐下降,菌量比为1:100时则提前至8 h,至120 h孵育结束活菌量均下降到102CFU/mL。结论鼠李糖乳杆菌和植物乳杆菌均能有效地竞争拮抗阪崎肠杆菌。     

双歧杆菌包埋保存技术工艺研究

采用一种全新的思路和方法,从将双歧杆菌活菌完全隔绝空气和降低其对温度的敏感性出发,运用制备微囊的方法,采用一种药用成膜材料,将包埋与冷冻干燥有机结合起来,在冷冻干燥的同时迅速在双歧杆菌活菌体周围形成一层类似微囊的保护膜,即将双歧杆菌活菌体包埋在保护膜内,从而达到减少甚至避免菌体冻干损伤,提高活菌存活率和收率,延长活菌常温保存期,提高活菌常温稳定性的目的。同时,这种包埋保存技术完全去除了常规冻干辅料——脱脂奶粉,能有效减少冷冻干燥菌粉的吸湿性,更利于活菌保存。用双歧杆菌包埋保存技术制备出的冻干菌粉,其含菌量比用常规冻干保护剂作冻干辅料的冻干菌粉高几百亿个／克,双歧杆菌活菌在37℃的保存期达四个月(相当于常温下保存一年以上),有效地解决了双歧杆菌活菌制剂常温保存期短的技术关键问题。     

复合活菌制剂对断奶仔猪生长性能及血清溶菌酶含量的影响

目的观察复合活菌制剂对断奶仔猪生长性能及血清溶菌酶含量的影响。方法选择长白二元杂交断奶仔猪90头进行实验,断奶日龄为35 d。共分为5个组,每组设3个重复,每个重复随机选取健康仔猪6头。实验组一:饲喂基础日粮+0.1%复合制剂(纳豆杆菌,双歧杆菌,罗伊乳杆菌),实验组二:饲喂基础日粮+0.1%复合制剂(纳豆杆菌,双歧杆菌,干酪乳杆菌),实验组三:饲喂基础日粮+0.1%复合制剂(纳豆杆菌,双歧杆菌,嗜酸乳杆菌),实验组四:饲喂基础日粮+0.1%复合制剂(纳豆杆菌,双歧杆菌,罗伊乳杆菌,干酪乳杆菌,嗜酸乳杆菌),对照组:饲喂基础日粮。其中复合制剂中益生菌活菌数为109CFU/g。饲养30 d后观察复合活菌制剂对断奶仔猪生长性能及血清溶菌酶含量的影响。结果在日增重、饲料效率及血清溶菌酶方面,实验组一和二显著高于对照组(P0.05);在腹泻率方面,实验组均显著低于对照组(P0.05)。结论在仔猪日粮中添加复合活菌制剂可提高每头断奶仔猪平均日增重及饲料效率,降低腹泻的发病率,且增高仔猪血清溶菌酶含量,提高仔猪的免疫机能,从而提高经济效益。     

环丙沙星预先处理牙鲆消化道对干酪乳杆菌定植的影响

利用1株干酪乳杆菌,通过实验研究用环丙沙星预先处理牙鲆消化道后乳杆菌的定植和演替规律。在投喂含有1.2×10^9CFU/g乳杆菌的饲料5 d后,消化道定植的乳杆菌超过106CFU/g,其后维持在10^6～10^8CFU/g动态平衡中。同时随着乳杆菌的投喂,不经环丙沙星预先处理牙鲆消化道的正常组,鱼消化道的弧菌数从10^7～8CFU/g降低到10^6CFU/g左右;而经环丙沙星预先处理牙鲆消化道的药饵组,鱼胃、小肠和盲囊的弧菌数则是先增加,然后显著下降。停喂乳杆菌7 d后,2个实验组鱼消化道的乳杆菌均从10^5～6CFU/g下降到10^4CFU/g,干酪乳杆菌正常组鱼盲囊中弧菌从10^5CFU/g回升到10^6CFU/g,胃和小肠中弧菌数量基本不变。干酪乳杆菌药饵组则有所不同：除胃中弧菌数量则基本不变外,盲囊和小肠中弧菌数量继续下降,其原因有待进一步研究。实验结果表明,干酪乳杆菌能在牙鲆消化道内定植,而用预先处理牙鲆消化道后,更有利于乳杆菌的定植;乳杆菌的投喂和定植,使牙鲆消化道中的弧菌数量明显下降。     

Rapid detection of viable salmonellae in produce by coupling propidium monoazide with loop-mediated isothermal amplification

Recent outbreaks linked to Salmonella-contaminated produce heightened the need to develop simple, rapid, and accurate detection methods, particularly those capable of determining cell viability. In this study, we examined a novel strategy for the rapid detection and quantification of viable salmonellae in produce by coupling a simple propidium monoazide sample treatment with loop-mediated isothermal amplification (PMA-LAMP). We first designed and optimized a LAMP assay targeting Salmonella. Second, the performance of PMA-LAMP for detecting and quantifying viable salmonellae was determined. Finally, the assay was evaluated in experimentally contaminated produce items (cantaloupe, spinach, and tomato). Under the optimized condition, PMA-LAMP consistently gave negative results for heat-killed Salmonella cells with concentrations up to 10(8) CFU/ml (or CFU/g in produce). The detection limits of PMA-LAMP were 3.4 to 34 viable Salmonella cells in pure culture and 6.1 × 10(3) to 6.1 × 10(4) CFU/g in spiked produce samples. In comparison, PMA-PCR was up to 100-fold less sensitive. The correlation between LAMP time threshold (T(T)) values and viable Salmonella cell numbers was high (R(2) = 0.949 to 0.993), with a quantification range (10(2) to 10(5) CFU/reaction in pure culture and 10(4) to 10(7) CFU/g in produce) comparable to that of PMA in combination with quantitative real-time PCR (PMA-qPCR). The complete PMA-LAMP assay took about 3 h to complete when testing produce samples. In conclusion, this rapid, accurate, and simple method to detect and quantify viable Salmonella cells in produce may present a useful tool for the produce industry to better control potential microbial hazards in produce.     

Enhanced immunomodulatory activity and stability in simulated digestive juices of Lactobacillus plantarum L-137 by heat treatment

This study reports the effect of heat treating Lactobacillus plantarum L-137 on its in vitro cytokine-inducing activity, on the stability of this activity in simulated digestive juices, and on its in vivo immunomodulatory properties. L-137 cells were harvested at the stationary phase with or without the subsequent heat treatment and then lyophilized. Heat-killed L-137 cells stimulated mouse spleen cells to produce more interleukin-12p40 than unheated L-137. The interleukin-12p40-inducing activity of unheated L-137 was significantly lower when incubated with simulated intestinal juice, but the activity of heat-killed L-137 cells was maintained. Furthermore, heat-killed L-137 was more protective than unheated L-137 in a mouse model of dextran sulfate sodium-induced colitis. A heat treatment may therefore be effective for enhancing the immunomodulatory activity of L-137 cells.     

Antihypertensive effect of Cecropia obtusifolia (Moraceae) leaf extract on rats

A lyophilized aqueous leaf extract of Cecropia obtusifolia proved to be antihypertensive when intravenously administrated to conscious spontaneous hypertensive rats. Forty-five minutes after injection, the maximum fall in arterial pressure (-23.5% relative to preinjection values) was seen and recovery was not complete by the end of the 180 min observation period. The extract was also given to pre-hypertensive SHR and normotensive rats. The fall in blood pressure was more conspicuous in the two SHr groups and was not accompanied by changes in cardiac frequency in any group. This would appear to rule out either a direct or indirect involvement of the heart in regard to the observed hypotension.     

长双歧杆菌DD98冻干保护剂优化及菌粉保存稳定性研究

以长双歧杆菌DD98为研究对象,通过对冻干保护剂配方的优化,冻干菌粉的存活率提高到90%以上。通过进一步稳定性研究,采用保护剂优化配方制备的冻干菌粉在4℃保存24个月后,活菌数仍在1.0×10^10 CFU/g以上,在25℃条件下可以保存12个月,双歧杆菌的存活率在1.0×10^6CFU/g以上,符合FAO/WHO建议食品益生菌活菌数应在1.0×10^6 CFU/g^1.0×10^7CFU/g的标准。     

Fura-2 used as a probe to show elevated intracellular free calcium in platelets of Dahl-sensitive rats fed a high salt diet

Elevated intracellular free calcium concentration [Ca2+]i in vascular smooth muscle cells has been implicated in the pathophysiology of hypertension. Platelet [Ca2+]i was measured using the fluorescent indicator, Fura-2, in Dahl sensitive (DS) and resistant (DR) rats given high (8% NaCl) and low (0.4% NaCl) salt diets, as well as in the spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats. The aim of this study was to show whether [Ca2+]i is elevated in salt induced hypertension. Platelet [Ca2+]i and systolic blood pressure (SBP) were higher (p less than 0.001) in DS rats given a high than low salt diets. In contrast, no changes in platelet [Ca2+]i and SBP were observed in DR rats. In SHR, platelet [Ca2+]i and SBP were higher (p less than 0.001) than in the WKY rats. Platelet [Ca2+]i correlated with SBP in all groups of rats (r = 0.929; p less than 0.001, n = 38). The parallel increase in SBP and [Ca2+]i in the DS high salt rats and the SHR suggests that an increased [Ca2+]i is involved in the pathophysiology of hypertension in the two models which differ with respect to the pathogenesis of their hypertension. This increase in [Ca2+]i therefore seems to reflect an abnormality in [Ca2+]i handling in hypertension regardless of its cause.     

原发性高血压患者红细胞抗高血压因子对高血压...

The effects of antihypertensive factor (AHF) from erythrocytes of essential hypertensive human subjects on the systolic blood pressure (SBP) and diastolic blood pressure (DBP) in spontaneously hypertensive rats (SHR), renal hypertensive rats (RHR), Wistar-Kyoto rats (WKY) and Wistar rats were examined. Single intraperitoneal injection of AHF (1.6 mg/kg body weight) resulted in a significant decrease in SBP of SHR and RHR. At 10 min postinjection, AHF lowered the SBP in SHR by 34.0 mmHg. SBP recovered to the original level at 3 h. The maximal decrease of SBP in RHR by 92.5 mmHg was at 24h postadministration and the SBP did not recover until the 9th day. When AHF was administered via femoral vein (0.8 mg/kg body weight), the maximal decrease values of the SBP and the DBP were 42.8 and 48.2 mmHg in SHR at 12 min and 38.3 and 42.5 mmHg in RHR at 25 min postinjection respectively. The DBP in Wistar rats decreased considerably (from 96.7 +/- 12.9 to 83.3 +/- 11.7 mmHg) at 5 min postadministration of AHF, but no effect on DBP in WKY rats was observed. The depressor effect of AHF on SBP in RHR was dose-dependent. AHF could also antagonize the pressor effect of norepinephrine in Wistar rats.     

Candida albicans viability after exposure to amphotericin B: assessment using metabolic assays and colony forming units

Metabolic assays are a preferred method for evaluation of Candida albicans viability after exposure to antimicrobial agents in cases in which the culture is a complex mixture of yeast and filamentous forms. There is a lack of published data indicating the strength of the correlation between metabolic assays and viable cell numbers determined by a standard assay such as colony forming units (CFU). We developed a kinetic metabolic assay (KMA) for quantifying viable cells which was tested on yeast cells in both exponential and stationary phase using alamarBlue and XTT as metabolic indicators. The KMA enabled quantification of the viable population over a range of 10(1) to 10(7) cells that linearly correlated (R(2)>0.98) with estimates made by enumeration of CFU regardless of the indicator or growth phase of the cells. Linear relationships were used to calibrate the KMA in terms of equivalent CFU. Viable cell populations were then determined after exposure to AmB. These results were compared with those obtained by direct enumeration of CFU. There were significant correlations between KMA-derived equivalent CFU and direct CFU estimates of viable cell populations for exponential-phase cells. However, the proportions of viable cells based on the KMA were consistently lower than those obtained directly by CFU. This trend was substantially more pronounced for stationary phase cells. These results show that even in the relatively simple case in which only the yeast form is present, the relationship between assessment by metabolic assays and CFU is perturbed by exposure to an antimicrobial and that, furthermore, growth phase alters the nature of the perturbation.     

Enhanced Immunomodulatory Activity and Stability in Simulated Digestive Juices of Lactobacillus plantarum L-137 by Heat Treatment

This study reports the effect of heat treating Lactobacillus plantarum L-137 on its in vitro cytokine-inducing activity, on the stability of this activity in simulated digestive juices, and on its in vivo immunomodulatory properties. L-137 cells were harvested at the stationary phase with or without the subsequent heat treatment and then lyophilized. Heat-killed L-137 cells stimulated mouse spleen cells to produce more interleukin-12p40 than unheated L-137. The interleukin-12p40-inducing activity of unheated L-137 was significantly lower when incubated with simulated intestinal juice, but the activity of heat-killed L-137 cells was maintained. Furthermore, heat-killed L-137 was more protective than unheated L-137 in a mouse model of dextran sulfate sodium-induced colitis. A heat treatment may therefore be effective for enhancing the immunomodulatory activity of L-137 cells.     

Discrimination of viable and dead Vibrio vulnificus after refrigerated and frozen storage using EMA, sodium deoxycholate and real-time PCR

The effect of refrigerated and frozen storage on the viability of Vibrio vulnificus was evaluated using cell suspensions (1 × 10⁸ CFU/ml). Ethidium bromide monoazide (EMA) was utilized to selectively allow real-time (Rti) PCR amplification of target DNA from viable but not dead cells. Bacterial survivors from the EMA Rti-PCR were evaluated by comparison with the plate count assay following different temperature exposures (− 20 and 4 °C) every 24 h for 72 h. The log CFU values from the EMA Rti-PCR assays were erroneously higher than that from plate counts. DNA amplification was not completely suppressed by EMA treatment of low temperature destroyed cells suggesting that membrane damage was not sufficient to allow effective EMA penetration into the cells. The optimal concentration of sodium deoxycholate (SD) was also determined to enhance discrimination of viable and dead cells following exposure of cells to low temperatures. The use of 0.01% or less of SD did not inhibit the Rti-PCR amplification derived from viable bacterial cells. A rapid decrease of the log CFU was observed with cell suspensions subjected to frozen storage and a slow decline in the log CFU occurred at 4 °C. The combination of SD and EMA treatments applied to cells of V. vulnificus held at − 20 °C and 4 °C resulted in a high level of correlation between the log of CFU (plate counts) and the log of the number of viable cells determined from SD+EMA Rti-PCR.     

Live encapsulated Lactobacillus acidophilus cells in yogurt for therapeutic oral delivery: preparation and in vitro analysis of alginate-chitosan microcapsules

Targeted delivery of live microencapsulated bacterial cells has strong potential for application in treating various diseases, including diarrhea, kidney failure, liver failure, and high cholesterol, among others. This study investigates the potential of microcapsules composed of two natural polymers, alginate and chitosan (AC), and the use of these artificial cells in yogurt for delivery of probiotic Lactobacillus acidophilus bacterial live cells. Results show that the integrity of AC microcapsules was preserved after 76 h of mechanical shaking in MRS broth and after 12 h and 24 h in simulated gastric and intestinal fluids. Using an in vitro computer-controlled simulated human gastrointestinal (GI) model, we found 8.37 log CFU/mL of viable bacterial cells were present after 120 min of gastric exposure and 7.96 log CFU/mL after 360 min of intestinal exposure. In addition, AC microcapsules composed of chitosan 10 and 100 at various concentrations were subjected to 4-week storage in 2% milk fat yogurt or 0.85% physiological solution. It was found that 9.37 log CFU/mL of cells encapsulated with chitosan 10 and 8.24 log CFU/mL of cells encapsulated with chitosan 100 were alive after 4 weeks. The AC capsule composed of 0.5% chitosan 10 provided the highest bacterial survival of 9.11 log CFU/mL after 4 weeks. Finally, an investigation of bacterial viability over 72 h in different pH buffers yielded highest survival of 6.34 log CFU/mL and 10.34 log CFU/mL at pH 8 for free and AC-encapsulated cells, respectively. We conclude from these findings that encapsulation allows delivery of a higher number of bacteria to desired targets in the GI tract and that microcapsules containing bacterial cells are good candidates for oral artificial cells for bacterial cell therapy.